{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T19:54:13Z","timestamp":1760471653651},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1991,11,1]],"date-time":"1991-11-01T00:00:00Z","timestamp":688953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1991,11]]},"DOI":"10.1007\/bf02244425","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T22:07:23Z","timestamp":1132006043000},"page":"322-328","source":"Crossref","is-referenced-by-count":48,"title":["Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal"],"prefix":"10.1007","volume":"105","author":[{"given":"Guy A.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Joharchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02244425_CR1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0028-3908(90)90110-D","volume":"29","author":"JM Barnes","year":"1990","unstructured":"Barnes JM, Barnes NM, Champaneria S, Costall B, Naylor RJ (1990a) Characterization and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(s)-zacopride in the forebrain of the rat. Neuropharmacology 29:1037\u20131046","journal-title":"Neuropharmacology"},{"key":"BF02244425_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00178966","volume":"342","author":"JM Barnes","year":"1990","unstructured":"Barnes JM, Barnes NM, Costall B, Naylor IL, Naylor RJ, Rudd JA (1990b) Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem. Naunyn-Schmiedebergs Arch Pharmacol 342:17\u201321","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"BF02244425_CR3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0091-3057(90)90385-U","volume":"35","author":"JM Barnes","year":"1990","unstructured":"Barnes JM, Costall B, Coughlan J, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ, Onaivi ES, Tomkins DM, Tyers MB (1990c) The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 35:955\u2013962","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244425_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00428791","volume":"33","author":"J Blasig","year":"1973","unstructured":"Blasig J, Reinhold K, Zieglgansberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacology 33:19\u201338","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR5","first-page":"25","volume":"84","author":"AR Childress","year":"1988","unstructured":"Childress AR, McLellan AT, Ehrman R, O'Brien CP (1988) Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res Mongr 84:25\u201343","journal-title":"NIDA Res Mongr"},{"key":"BF02244425_CR6","first-page":"383","volume":"8","author":"P Chopin","year":"1987","unstructured":"Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. TIPS 8:383\u2013388","journal-title":"TIPS"},{"key":"BF02244425_CR7","first-page":"404","volume":"184","author":"TJ Cicero","year":"1973","unstructured":"Cicero TJ, Meyer ER (1973) Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence. J Pharmacol Exp Ther 184:404\u2013408","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244425_CR8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1476-5381.1987.tb11394.x","volume":"92","author":"B Costall","year":"1987","unstructured":"Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of rat and marmoset brain. Br J Pharmacol 92:881\u2013894","journal-title":"Br J Pharmacol"},{"key":"BF02244425_CR9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0091-3057(89)90273-6","volume":"34","author":"B Costall","year":"1989","unstructured":"Costall B, Jones BJ, Kelly ME, Naylor RJ, Oakley NR, Onaivi ES, Tyers MB (1989a) The effect of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 34:769\u2013778","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244425_CR10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1476-5381.1989.tb11821.x","volume":"96","author":"B Costall","year":"1989","unstructured":"Costall B, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1989b) Neuroanatomical sites of action of 5-HT3 receptor agonists and antagonists for alteration of aversive behaviour in the mouse. Br J Pharmacol 96:325\u2013332","journal-title":"Br J Pharmacol"},{"key":"BF02244425_CR11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(90)90414-D","volume":"36","author":"B Costall","year":"1990","unstructured":"Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990a) Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacol Biochem Behav 36:339\u2013344","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244425_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-3057(90)90132-2","volume":"36","author":"B Costall","year":"1990","unstructured":"Costall B, Jones BJ, Kelly ME, Naylor RJ, Onaivi ES, Tyers MB (1990b) Sites of action of ondansetron to inhibit withdrawal from drugs of abuse. Pharmacol Biochem Behav 36:97\u2013104","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244425_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-198702000-00006","volume":"7","author":"I Csanalosi","year":"1987","unstructured":"Csanalosi I, Schweizer E, Chase WG, Rickels K (1987) Gepirone in anxiety: a pilot study. J Clin Psychopharmacol 7:31\u201333","journal-title":"J Clin Psychopharmacol"},{"key":"BF02244425_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF02244046","volume":"101","author":"MW Emmett-Oglesby","year":"1990","unstructured":"Emmett-Oglesby MW, Mathis DA, Moon RTY, Lal H (1990) Animal models of drug withdrawal symptoms. Psychopharmacology 101:292\u2013309","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR15","first-page":"7","volume":"211","author":"AR Gintzler","year":"1979","unstructured":"Gintzler AR (1979) Serotonin participation in gut withdrawal from opiates. J Pharmacol Exp Ther 211:7\u201312","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244425_CR16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0014-2999(90)90638-M","volume":"185","author":"AJ Goudie","year":"1990","unstructured":"Goudie AJ, Leathley MJ (1990) Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats. Eur J Pharmacol 185:170\u2013186","journal-title":"Eur J Pharmacol"},{"key":"BF02244425_CR17","first-page":"363","volume":"474","author":"TH Hand","year":"1988","unstructured":"Hand TH, Koob GF, Stinus L, Le Moal M (1988) Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res 474:363\u2013368","journal-title":"Brain Res"},{"key":"BF02244425_CR18","unstructured":"Higgins GA, Jones BJ, Oakley NR, Tyers MB (1989a) Evidence that the amygdala and not the area postrema is involved in the putative anxiolytic effects of 5-HT3 receptor antagonists. Br J Pharmacol 98:635P"},{"key":"BF02244425_CR19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1476-5381.1989.tb11948.x","volume":"97","author":"GA Higgins","year":"1989","unstructured":"Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB (1989b) 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97:247\u2013255","journal-title":"Br J Pharmacol"},{"key":"BF02244425_CR20","doi-asserted-by":"crossref","unstructured":"Higgins GA, Jones BJ, Oakley NR, Tyers MB (1991) Evidence that the amygdala is involved in the disinhibitory effect of 5-HT3 receptor antagonists. Psychopharmacology (in press)","DOI":"10.1007\/BF02245664"},{"key":"BF02244425_CR21","first-page":"54","volume":"204","author":"SM Johnson","year":"1978","unstructured":"Johnson SM, Westfall DP, Howard SA, Fleming WW (1978) Sensitivities of the isolated ileal longitudinal smooth muscle-myenteric plexus and hypogastric nerve-vas deferens of the guinea pig after chronic morphine pellet implantation. J Pharmacol Exp Ther 204:54\u201366","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244425_CR22","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1476-5381.1988.tb11489.x","volume":"93","author":"BJ Jones","year":"1988","unstructured":"Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR38032F, a 5-HT3 receptor antagonist. Br J Pharmacol 93:985\u2013993","journal-title":"Br J Pharmacol"},{"key":"BF02244425_CR23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00735872","volume":"94","author":"JH Kehne","year":"1988","unstructured":"Kehne JH, Cassella JV, Davis M (1988) Anxiolytic effects of buspirone and gepirone in the fear potentiated startle paradigm. Psychopharmacology 94:8\u201313","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(89)90700-0","volume":"159","author":"GJ Kilpatrick","year":"1989","unstructured":"Kilpatrick GJ, Jones BJ, Tyers MB (1989) Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol 159:157\u2013164","journal-title":"Eur J Pharmacol"},{"key":"BF02244425_CR25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0091-3057(88)90192-X","volume":"29","author":"JL Koenig","year":"1988","unstructured":"Koenig JL, Meltzer HY, Gudelsky GA (1988) 5-Hydroxytryptamine1A receptor mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav 29:711\u2013715","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244425_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00421383","volume":"46","author":"E Laschka","year":"1976","unstructured":"Laschka E, Teschemacher H, Mehraein P, Herz A (1976) Sites of action of morphine involved in the development of physical dependence in rats. Psychopharmacology 46:141\u2013147","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR27","unstructured":"Lecrubier Y (1991) 5-HT3 receptors in anxiety disorders. J Psychopharmacol (in press)"},{"key":"BF02244425_CR28","doi-asserted-by":"crossref","unstructured":"Liebundgut U, Lancranjan I (1987) First results with ICS 205\u2013930 (5-HT3 antagonist) in prevention of chemotherapy-induced emesis. Lancet i:1198","DOI":"10.1016\/S0140-6736(87)92159-3"},{"key":"BF02244425_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00431636","volume":"51","author":"FJ Manning","year":"1977","unstructured":"Manning FJ, Jackson MC Jr. (1977) Enduring effects of morphine pellets revealed by conditioned taste aversion. Psychopharmacology 51:279\u2013283","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1476-5381.1986.tb10228.x","volume":"88","author":"WD Miner","year":"1986","unstructured":"Miner WD, Sanger GJ (1986) Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497\u2013499","journal-title":"Br J Pharmacol"},{"key":"BF02244425_CR31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0006-8993(87)90088-6","volume":"418","author":"RF Mucha","year":"1987","unstructured":"Mucha RF (1987) Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res 418:214\u2013220","journal-title":"Brain Res"},{"key":"BF02244425_CR32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00427782","volume":"82","author":"RF Mucha","year":"1984","unstructured":"Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology 82:241\u2013247","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(82)91123-4","volume":"243","author":"RF Mucha","year":"1982","unstructured":"Mucha RF, Van der Kooy D, O'Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91\u2013105","journal-title":"Brain Res"},{"key":"BF02244425_CR34","first-page":"567","volume":"75","author":"RF Mucha","year":"1986","unstructured":"Mucha RF, Gritti MD, Kim C (1986) Aversive properties of opiate withdrawal studied in rats. NIDA Res Monogr 75:567\u2013570","journal-title":"NIDA Res Monogr"},{"key":"BF02244425_CR35","unstructured":"Oakley NR, Jones, BJ, Tyers MB, Costall B, Domeney AM (1988) The effect of GR38032F on alcohol consumption in the marmoset. Br J Pharmacol 95:870P"},{"key":"BF02244425_CR36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0014-2999(89)90797-8","volume":"168","author":"LM Pinkus","year":"1989","unstructured":"Pinkus LM, Sarbin NS, Barefoot DS, Gordon JC (1989) Association of [3H]zacopride with 5-HT3 binding sites. Eur J Pharmacol 168:355\u2013362","journal-title":"Eur J Pharmacol"},{"key":"BF02244425_CR37","first-page":"135","volume":"11","author":"GD Pratt","year":"1990","unstructured":"Pratt GD, Bowery NG, Kilpatrick GJ, Leslie RA, Barnes NM, Naylor RJ, Jones BJ, Nelson DR, Palacios JM, Slater P, Reynolds DJM (1990) Concensus meeting agrees distribution of 5-HT3 receptors in mammalian hindbrain. TIPS 11:135\u2013137","journal-title":"TIPS"},{"key":"BF02244425_CR38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00174511","volume":"95","author":"GC Preston","year":"1988","unstructured":"Preston GC, Broks P, Traub M, Ward C, Poppleton P, Stahl SM (1988) Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology 95:208\u2013215","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR39","first-page":"424","volume":"9","author":"BP Richardson","year":"1986","unstructured":"Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. TINS 9:424\u2013428","journal-title":"TINS"},{"key":"BF02244425_CR40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00690922","volume":"91","author":"PP Roy-Byrne","year":"1987","unstructured":"Roy-Byrne PP, Uhde TW, Holcomb H, Thomspon K, King AK, Weingartner H (1987) Effects of diazepam on cognitive process in normal subjects. Psychopharmacology 91:30\u201333","journal-title":"Psychopharmacology"},{"key":"BF02244425_CR41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/244168a0","volume":"244","author":"R Schultz","year":"1973","unstructured":"Schultz R, Goldstein A (1973) Morphine tolerance and supersensitivity to 5-hydroxytryptamine in the myenteric plexus of the guinea-pig. Nature 244:168\u2013170","journal-title":"Nature"},{"key":"BF02244425_CR42","first-page":"1533","volume":"118","author":"EM Sellers","year":"1978","unstructured":"Sellers EM (1978) Clinical pharmacology and therapeutics of benzodiazepines. Can Med Assoc J 118:1533\u20131538","journal-title":"Can Med Assoc J"},{"key":"BF02244425_CR43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0091-3057(89)90489-9","volume":"33","author":"LG Sharpe","year":"1989","unstructured":"Sharpe LG, Jaffe JH (1989) Captopril and capsaicin modify opioid withdrawal in the morphine-dependent rat. Pharmacol Biochem Behav 33:899\u2013902","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244425_CR44","first-page":"1","volume":"84","author":"S Siegel","year":"1988","unstructured":"Siegel S (1988) Drug anticipation and the treatment of dependence. NIDA Res Mongr 84:1\u201324","journal-title":"NIDA Res Mongr"},{"key":"BF02244425_CR45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0306-4522(90)90106-E","volume":"37","author":"L Stinus","year":"1990","unstructured":"Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767\u2013773","journal-title":"Neuroscience"},{"key":"BF02244425_CR46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(90)90090-S","volume":"181","author":"C Waeber","year":"1990","unstructured":"Waeber C, Pinkus LM, Palacios JM (1990) The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain. Eur J Pharmacol 181:283\u2013287","journal-title":"Eur J Pharmacol"},{"key":"BF02244425_CR47","first-page":"398","volume":"184","author":"E Wei","year":"1973","unstructured":"Wei E, Loh HH, Way EL (1973) Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther 184:398\u2013403","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244425_CR48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1037\/0021-843X.97.2.118","volume":"97","author":"RA Wise","year":"1988","unstructured":"Wise RA (1988) The neurobiology of craving: implication for the understanding and treatment of addiction. J Abnorm Psychol 97:118\u2013132","journal-title":"J Abnorm Psychol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02244425\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T23:32:03Z","timestamp":1557876723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02244425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,11]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,11]]}},"alternative-id":["BF02244425"],"URL":"https:\/\/doi.org\/10.1007\/bf02244425","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,11]]}}}